Literature DB >> 17133478

Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist?

Fabien Zoulim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133478     DOI: 10.1002/hep.21451

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

Review 1.  Emerging drugs for hepatitis B.

Authors:  Fabien Zoulim
Journal:  Expert Opin Emerg Drugs       Date:  2007-05       Impact factor: 4.191

2.  Dynamics of lamivudine-resistant hepatitis B virus strains in patients with entecavir rescue therapy.

Authors:  Xiao-Lin Deng; Qing-Ling Li; Jin-Jun Guo
Journal:  Virus Genes       Date:  2013-04-25       Impact factor: 2.332

3.  Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.

Authors:  Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozheng Xu; Jessica Liu; Dong Xu; Cyril Llamoso
Journal:  Hepatol Int       Date:  2008-08-30       Impact factor: 6.047

4.  Pseudomonas exotoxin antisense RNA selectively kills hepatitis B virus infected cells.

Authors:  Peter Hafkemeyer; Ulrich Brinkmann; Elizabeth Brinkmann; Ira Pastan; Hubert-E Blum; Thomas-F Baumert
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

5.  HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining.

Authors:  Xizhan Xu; Kuanhui Xiang; Mingze Su; Yao Li; Wei Ji; Yutang Li; Hui Zhuang; Tong Li
Journal:  Viruses       Date:  2017-07-27       Impact factor: 5.048

6.  Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy.

Authors:  Yang Wang; Shuang Liu; Y U Chen; Sujun Zheng; L I Zhou; Tsen Hua; Shaofei Sui; Fengmin Lu; Zhongping Duan
Journal:  Exp Ther Med       Date:  2015-11-12       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.